MDGL – Madrigal Pharmaceuticals Inc
MDGL — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
9.58
Margin Of Safety %
Put/Call OI Ratio
0.57
EPS Next Q Diff
-1.31
EPS Last/This Y
6.36
EPS This/Next Y
16.12
Price
509.58
Target Price
678.18
Analyst Recom
1.16
Performance Q
-4.64
Upside
-188.4%
Beta
-1
Ticker: MDGL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | MDGL | 531.46 | 0.40 | 6.69 | 18085 |
| 2026-07-14 | MDGL | 536.74 | 0.40 | 0.30 | 18142 |
| 2026-07-15 | MDGL | 549.31 | 0.40 | 0.33 | 18204 |
| 2026-07-16 | MDGL | 545.59 | 0.41 | 0.42 | 18336 |
| 2026-07-17 | MDGL | 553.79 | 0.41 | 0.52 | 18374 |
| 2026-07-20 | MDGL | 535.96 | 0.43 | 1.22 | 10217 |
| 2026-07-21 | MDGL | 546.21 | 0.43 | 0.41 | 10474 |
| 2026-07-22 | MDGL | 536.83 | 0.43 | 2.25 | 10587 |
| 2026-07-23 | MDGL | 543.62 | 0.43 | 3.54 | 10625 |
| 2026-07-24 | MDGL | 544.81 | 0.46 | 0.28 | 10876 |
| 2026-07-27 | MDGL | 551.25 | 0.46 | 0.12 | 10982 |
| 2026-07-28 | MDGL | 538.54 | 0.45 | 0.17 | 11028 |
| 2026-07-29 | MDGL | 546.23 | 0.45 | 1.42 | 11108 |
| 2026-07-30 | MDGL | 492.94 | 0.46 | 1.06 | 11217 |
| 2026-07-31 | MDGL | 467.39 | 0.51 | 0.85 | 12499 |
| 2026-08-03 | MDGL | 482.19 | 0.54 | 0.42 | 13136 |
| 2026-08-04 | MDGL | 507.56 | 0.53 | 0.11 | 13330 |
| 2026-08-05 | MDGL | 513.96 | 0.54 | 5.21 | 13249 |
| 2026-08-06 | MDGL | 509.02 | 0.57 | 0.20 | 13465 |
| 2026-08-07 | MDGL | 508.7 | 0.57 | 0.10 | 13393 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | MDGL | 531.02 | -17.4 | - | -6.52 |
| 2026-07-14 | MDGL | 536.80 | -17.4 | - | -6.52 |
| 2026-07-15 | MDGL | 550.27 | -17.4 | - | -6.52 |
| 2026-07-16 | MDGL | 544.15 | -17.4 | - | -6.52 |
| 2026-07-17 | MDGL | 553.31 | -17.4 | - | -6.52 |
| 2026-07-20 | MDGL | 536.03 | -17.4 | - | -6.52 |
| 2026-07-21 | MDGL | 547.32 | -17.4 | - | -6.52 |
| 2026-07-22 | MDGL | 536.87 | -17.4 | - | -6.52 |
| 2026-07-23 | MDGL | 543.48 | -17.4 | - | -6.52 |
| 2026-07-24 | MDGL | 544.69 | -17.4 | - | -6.52 |
| 2026-07-27 | MDGL | 551.25 | -17.4 | - | -6.52 |
| 2026-07-28 | MDGL | 538.70 | -17.4 | - | -6.52 |
| 2026-07-29 | MDGL | 546.81 | -17.4 | - | -6.52 |
| 2026-07-30 | MDGL | 492.35 | -17.4 | - | -6.52 |
| 2026-07-31 | MDGL | 467.55 | -17.4 | - | -6.52 |
| 2026-08-03 | MDGL | 482.19 | -17.4 | - | -6.52 |
| 2026-08-04 | MDGL | 482.19 | -17.4 | - | -6.52 |
| 2026-08-05 | MDGL | 513.82 | 73.7 | - | -7.17 |
| 2026-08-06 | MDGL | 510.55 | 73.7 | - | -7.17 |
| 2026-08-07 | MDGL | 509.58 | 78.1 | - | -6.49 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | MDGL | -4.40 | 2.98 | 16.27 |
| 2026-07-14 | MDGL | -1.42 | 2.98 | 16.27 |
| 2026-07-15 | MDGL | -1.42 | 2.98 | 16.27 |
| 2026-07-16 | MDGL | -1.42 | 2.98 | 16.27 |
| 2026-07-17 | MDGL | -1.42 | 2.98 | 16.27 |
| 2026-07-20 | MDGL | -1.42 | 3.02 | 16.27 |
| 2026-07-21 | MDGL | -1.39 | 3.02 | 16.27 |
| 2026-07-22 | MDGL | -1.39 | 3.02 | 16.27 |
| 2026-07-23 | MDGL | -1.39 | 3.02 | 16.27 |
| 2026-07-24 | MDGL | -1.39 | 3.02 | 16.27 |
| 2026-07-27 | MDGL | -1.02 | 3.11 | 9.60 |
| 2026-07-28 | MDGL | -1.02 | 3.11 | 9.60 |
| 2026-07-29 | MDGL | -1.02 | 3.11 | 9.60 |
| 2026-07-30 | MDGL | -1.02 | 3.11 | 9.60 |
| 2026-07-31 | MDGL | -1.02 | 3.11 | 9.60 |
| 2026-08-03 | MDGL | -1.02 | 0.48 | 9.58 |
| 2026-08-04 | MDGL | -1.02 | 0.48 | 9.58 |
| 2026-08-05 | MDGL | -1.02 | 0.48 | 9.58 |
| 2026-08-06 | MDGL | -1.02 | 0.48 | 9.58 |
| 2026-08-07 | MDGL | -1.02 | 0.48 | 9.58 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.89
Avg. EPS Est. Current Quarter
-1.09
Avg. EPS Est. Next Quarter
-0.42
Insider Transactions
-1.02
Institutional Transactions
0.48
Beta
-1
Average Sales Estimate Current Quarter
403
Average Sales Estimate Next Quarter
442
Fair Value
Quality Score
43
Growth Score
28
Sentiment Score
58
Actual DrawDown %
17.1
Max Drawdown 5-Year %
-61.4
Target Price
678.18
P/E
Forward P/E
77.86
PEG
P/S
9.18
P/B
22.49
P/Free Cash Flow
EPS
-12.88
Average EPS Est. Cur. Y
-6.49
EPS Next Y. (Est.)
9.62
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-25.32
Relative Volume
0.96
Return on Equity vs Sector %
-89.4
Return on Equity vs Industry %
-73.3
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
◆
MDGL
Healthcare
$510.04
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
46.7
Range 1M
50.6%
Sup Dist
1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
51.3%
EPS NY
204.6%
52W%
61.5%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-14.9% upside
Upside
-14.9%
Quality
43
MDGL — P/E HistoricalBiotechnology
Madrigal Pharmaceuticals, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 915
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
MDGL
Latest News
—
Caricamento notizie per MDGL…
stock quote shares MDGL – Madrigal Pharmaceuticals Inc Stock Price stock today
news today MDGL – Madrigal Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MDGL – Madrigal Pharmaceuticals Inc yahoo finance google finance
stock history MDGL – Madrigal Pharmaceuticals Inc invest stock market
stock prices MDGL premarket after hours
ticker MDGL fair value insiders trading